Liquidia Corporation Common Stock earnings per share and revenue
On 03 de nov. de 2025, LQDA reported earnings of -0.04 USD per share (EPS) for Q3 25, beating the estimate of -0.40 USD, resulting in a 90.23% surprise. Revenue reached 54.34 milhão, compared to an expected 19.20 milhão, with a 183.00% difference. The market reacted with a +3.53% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analistas forecast an EPS of 0.20 USD, with revenue projected to reach 85.43 milhão USD, implying an diminuir of -600.00% EPS, and aumentar of 57.20% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Liquidia Corporation Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Liquidia Corporation Common Stock reported EPS of -$0.04, beating estimates by 90.23%, and revenue of $54.34M, 183% above expectations.
How did the market react to Liquidia Corporation Common Stock's Q3 2025 earnings?
The stock price moved up 3.53%, changed from $24.36 before the earnings release to $25.22 the day after.
When is Liquidia Corporation Common Stock expected to report next?
The next earning report is scheduled for 17 de mar. de 2026.
What are the forecasts for Liquidia Corporation Common Stock's next earnings report?
Based on 11
analistas, Liquidia Corporation Common Stock is expected to report EPS of $0.20 and revenue of $85.43M for Q4 2025.